SCHEMBL23905355

SCHEMBL23905355

CCOC(=O)c1cc(OC)c2ncc(N)cc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 1/20 0.47
PDGFRB P09619 1/20 0.46
PDGFRA P16234 1/20 0.46
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAOA P21397 1/20 0.43
DPP4 P27487 7/20 0.43
NPC1 O15118 2/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
MAOB P27338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23905400 0.87 HSD17B2 (0.49) HSD17B2PDGFRBPDGFRADPP4NPC1
SCHEMBL23904824 0.85 HSD17B2 (0.47) HSD17B2PDGFRBPDGFRADPP4NPC1
SCHEMBL23905399 0.85 HSD17B2 (0.47) HSD17B2PDGFRBPDGFRALMNADPP4
SCHEMBL23904823 0.85 HSD17B2 (0.47) HSD17B2PDGFRBPDGFRADPP4NPC1
SCHEMBL23905885 0.84 HSD17B2 (0.46) HSD17B2PDGFRBPDGFRADPP4NPC1
SCHEMBL23905883 0.84 HSD17B2 (0.46) HSD17B2PDGFRBPDGFRALMNACYP1A2
SCHEMBL23905882 0.82 HSD17B2 (0.45) HSD17B2PDGFRBPDGFRADPP4NPC1
SCHEMBL23905356 0.82 CA12 (0.47) PDGFRBPDGFRALMNAMEN1KMT2A
SCHEMBL25114964 0.81 MAOB (0.45) HSD17B2PDGFRBPDGFRANPC1MEN1
SCHEMBL23905553 0.78 PDGFRB (0.49) HSD17B2PDGFRBPDGFRADPP4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 WO disclosed